Loading…

to bookmark your favorites and sync them to your phone or calendar.
Tuesday, January 14
 

7:15am PST

Networking Breakfast
Tuesday January 14, 2025 7:15am - 8:15am PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 7:15am - 8:15am PST
Hyatt Regency San Francisco
  Networking

7:15am PST

Registration
Tuesday January 14, 2025 7:15am - 5:00pm PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 7:15am - 5:00pm PST
Hyatt Regency San Francisco

8:15am PST

Opening Remarks
Tuesday January 14, 2025 8:15am - 8:20am PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Tuesday January 14, 2025 8:15am - 8:20am PST
Hyatt Regency San Francisco

8:20am PST

Opening Fireside Chat: Noubar Afeyan, Founder and CEO, Flagship Pioneering; Co-Founder and Chairman, Moderna
Tuesday January 14, 2025 8:20am - 8:40am PST
Hyatt Regency San Francisco


Moderators
avatar for Gabrielle Masson

Gabrielle Masson

Senior Editor, Fierce Biotech
Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →
Speakers
avatar for Noubar Afeyan

Noubar Afeyan

Founder and CEO, Flagship Pioneering; Co-Founder and Board Chairman, Moderna
Noubar Afeyan is founder and CEO of Flagship Pioneering. He is also co-founder and Board Chairman of Moderna.Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges facing human health and sustainability. They begin by asking “What if?” and iterate toward the unexpected answers resulting in the creation... Read More →
Tuesday January 14, 2025 8:20am - 8:40am PST
Hyatt Regency San Francisco
  Keynote

8:40am PST

Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence
Tuesday January 14, 2025 8:40am - 9:00am PST
Hyatt Regency San Francisco
With innovation in new modalities driving increased complexity in the pharmaceutical pipeline, there is increasingly urgent need to deliver speed, quality, cost-efficiency and improved environmental footprint in pharmaceutical manufacturing. CDMOs are innovating across a number of areas to deliver this transformation – including by employing artificial intelligence, bringing tangible use cases to a promising technology.

In this session, Mike Riley, CEO of Veranova and David Shrier, CEO and Co-Founder of Phorum AI, will discuss a novel collaboration between their companies and will discuss how innovations in AI can unlock the potential of great scientific teams to create exponential improvements - 10x or even 100x - in the efficiency of how pharmaceuticals are produced.
Speakers
avatar for Mike Riley

Mike Riley

CEO, Veranova
Mike Riley joined Veranova as Chief Executive Officer in May 2023. Mike has over 25 years of professional experience, the majority of which has been spent in the pharmaceutical contract development and manufacturing (CDMO) industry. Prior to joining Veranova, he spent 19 years at... Read More →
avatar for David Shrier

David Shrier

Co-Founder & CEO, Phorum.AI
David Shrier is a serial entrepreneur and globally renowned advisor on digital acceleration. He has extensive technology innovation experience, having led $11 billion of growth initiatives and taken a company public on the NYSE. He runs venture studio Visionary Future, where he has... Read More →
Tuesday January 14, 2025 8:40am - 9:00am PST
Hyatt Regency San Francisco
  Keynote

9:00am PST

Executive Interview: Keiko Oishi, President & COO, CMIC Holdings Co., Ltd.
Tuesday January 14, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Keiko Oishi

Keiko Oishi

President & COO, CMIC HOLDINGS Co., Ltd.
Tuesday January 14, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco

9:20am PST

Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations
Tuesday January 14, 2025 9:20am - 10:00am PST
Hyatt Regency San Francisco
With some of the industry’s top drugs moving toward patent cliffs later this decade, Big Pharma dealmakers have remained active despite economic uncertainties. The 2024 buyouts of Catalent, Alpine Immune Sciences and CymaBay Therapeutics—among others—showed that drugmakers were willing to strike deals for the right assets at the right prices. As the industry navigates the Inflation Reduction Act and other factors, biopharma leaders and venture capitalists on this panel will share their expectations for the year ahead.
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Christine (Chris) Fox

Christine (Chris) Fox

Executive Vice President, U.S. Commercial, Teva Pharmaceuticals
Christine (Chris) Fox was appointed Executive Vice President, U.S. Commercial on November 20, 2023, leading all commercial activities for Teva in the U.S., including Teva’s generics, biosimilars and innovative medicines business. Chris brings more than 30 years of healthcare industry... Read More →
avatar for Greg Graves

Greg Graves

Senior Partner, McKinsey & Company
Greg is a senior partner in McKinsey’s Life Sciences Practice, where he leads the practice’s strategy and corporate finance work. Greg focuses on defining winning corporate strategies in the face of industry disruption and market uncertainties. He works with companies across the... Read More →
avatar for Anis Ha

Anis Ha

SVP, Deputy General Counsel Transactions and Contracting, Eli Lilly and Company
Anis Ha serves as the Senior Vice President / Deputy General Counsel of Transactions and Contracting at Eli Lilly and Company. Anis is a broadly experienced executive with global pharmaceutical, biotechnology, and law firm experience. In his current role at Eli Lilly, Anis leads a... Read More →
avatar for Jeb Keiper

Jeb Keiper

CEO & President, Nimbus Therapeutics, LLC
Jeb Keiper, MS, MBA, is CEO and president of Nimbus Therapeutics, LLC, a Boston-based biotechnology company focused on developing breakthrough medicines for patients through precision small molecule design. Jeb has overseen the discovery and development of multiple programs into clinical... Read More →
avatar for Adam Pearson

Adam Pearson

Chief Strategy Officer, Astellas
As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient... Read More →
Tuesday January 14, 2025 9:20am - 10:00am PST
Hyatt Regency San Francisco
  Panel

10:00am PST

Networking Break
Tuesday January 14, 2025 10:00am - 10:30am PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 10:00am - 10:30am PST
Hyatt Regency San Francisco
  Networking

10:30am PST

Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
Tuesday January 14, 2025 10:30am - 10:50am PST
Hyatt Regency San Francisco
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Nelson Ambrogio

Nelson Ambrogio

President of Radiology, Bayer Pharmaceuticals
Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing... Read More →
Tuesday January 14, 2025 10:30am - 10:50am PST
Hyatt Regency San Francisco
  Executive Interview

10:50am PST

Harnessing Real-World Data and Analytics Across the Product Lifecycle: From Day One To Launch and Beyond
Tuesday January 14, 2025 10:50am - 11:10am PST
Hyatt Regency San Francisco
The right real-world data can make a difference at every stage of the life sciences product life cycle – from market research and clinical trial design to go-to-market and commercialization strategies. And the right technology should deliver a unified platform experience and single source of truth across the enterprise for high-fidelity patient insights, streamlined operations, aligned decision-making, and improved therapeutic options for patients.

Join Arif Nathoo (CEO and Co-Founder of Komodo Health) and Jorge Santos da Silva (CEO and Co-Founder of MoonLake Immunotherapeutic) for a discussion on how emerging biotechs and life sciences giants alike can harness the power of a unified platform powered by regulatory-grade real-world data to transform business strategy and deliver transformative treatments to patients in need.
Speakers
avatar for Arif Nathoo

Arif Nathoo

CEO and Co-Founder, Komodo Health
Arif Nathoo, MD, is co-founder and CEO at Komodo Health, a technology company building a platform for healthcare innovation and democratizing access to insights from real-world patient data. As CEO, he oversees data sciences, engineering, and product development initiatives for the... Read More →
avatar for Jorge Santos da Silva

Jorge Santos da Silva

CEO and Co-Founder, MoonLake Immunotherapeutic
Jorge Santos da Silva, PhD, is Chief Executive Officer and Co-Founder of MoonLake Immunotherapeutics. He also serves as an Executive Director in the Board of MoonLake Immunotherapeutics. Jorge founded MoonLake in 2021 and took it public on NASDAQ (ticker: MLTX) in 2022, in one of... Read More →
Tuesday January 14, 2025 10:50am - 11:10am PST
Hyatt Regency San Francisco
  Presentation

11:10am PST

Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
Tuesday January 14, 2025 11:10am - 12:00pm PST
Hyatt Regency San Francisco
As clinical trials expand across borders, sponsors face unique challenges that can slow progress and increase complexity. This panel will dive into the key hurdles holding sponsors back, from navigating varying regulatory requirements to overcoming cultural and language barriers. Industry experts will explore strategies to streamline regulatory approvals, improve trial efficiency across diverse regions, and leverage cultural insights to enhance patient recruitment and retention. Join us for a deep dive into the opportunities and solutions driving the future of international clinical trials.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Janet Hammond, MD, PhD

Janet Hammond, MD, PhD

Chief Development Officer, Atea Pharmaceuticals
Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities... Read More →
avatar for Eric A. Hughes, MD, PhD

Eric A. Hughes, MD, PhD

Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals
Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative... Read More →
avatar for Judith Ng-Cashin, M.D.

Judith Ng-Cashin, M.D.

Chief Medical Officer, Novotech
Judith Ng-Cashin, M.D. joined Novotech in 2023 as its Chief Medical Officer. With a rich background encompassing over two decades in the international pharmaceutical, biotech, and CRO sectors, Dr. Ng-Cashin plays a pivotal role in shaping Novotech's global multi-regional later-phase... Read More →
avatar for Keiko Oishi

Keiko Oishi

President & COO, CMIC HOLDINGS Co., Ltd.
Tuesday January 14, 2025 11:10am - 12:00pm PST
Hyatt Regency San Francisco
  Panel

12:00pm PST

Innovative Risk-Sharing Models for Biotech Success
Tuesday January 14, 2025 12:00pm - 12:20pm PST
Hyatt Regency San Francisco
Explore practical and flexible approaches to clinical trial partnerships, focusing on risk-sharing models that reduce financial burdens while fostering collaboration and commercial success.

Key Highlights:
  • Performance-Based Models: Share financial risks with clear goals and incentives for strategic alignment.
  •  Revenue Sharing for Biotech: Support smaller firms and innovative therapies with shared financial burdens and future revenue potential.
  •  Hybrid Approaches: Combine milestone-based payments with revenue-sharing elements to balance commitment and flexibility.
Speakers
avatar for John Murray

John Murray

VP Global Business Development & Country Head UK, SanaClis
John Murray leverages his profound experience within the drug development sphere across multiple disciplines, from clinical operations, supply chain, sourcing and risk mitigation co-investment. John is brokering new strategic partnerships and developing existing collaborations between... Read More →
Tuesday January 14, 2025 12:00pm - 12:20pm PST
Hyatt Regency San Francisco
  Presentation

12:20pm PST

Networking Lunch
Tuesday January 14, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
  Networking

1:20pm PST

Panel: Our AI future: A Sector-by-Sector Breakdown
Tuesday January 14, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
As AI and machine learning continue to reshape biotech, medtech, and pharma, this panel will explore the latest trends, challenges, and opportunities for AI-driven advancements across these sectors. Experts will take an in-depth look at how AI is streamlining processes—from drug discovery to medical device development—and share real-world examples of its impact on patient care.
Moderators
avatar for Zoey Becker

Zoey Becker

Staff Writer, Fierce Pharma
Zoey Becker is a staff writer for Fierce Pharma. She joined the Fierce team in 2022 after interning at the Cincinnati Herald. Zoey is a graduate of Miami University, where she earned a degree in journalism as well as sociology. She currently resides in Chicago with her two goldfi... Read More →
Speakers
avatar for Alexandra Goncalves

Alexandra Goncalves

VP & Head of Digital Health, Bristol Myers Squibb
Dr. Alexandra Goncalves is an internationally recognized academic cardiologist with a business acumen and serves as VP and Head of Digital Health at Bristol Meyers Squibb, leading DH business strategy and execution across all company portfolio, from clinical development to commercialization.Prior... Read More →
avatar for Lars Fogh Iversen, PhD

Lars Fogh Iversen, PhD

Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S
Lars has held his current role since early 2022 and is responsible for accelerating the digital transformation of R&ED and driving scientific innovation beyond the limits of human cognition through the purpose of DSI.A long-time employee of Novo Nordisk, Lars has held a variety of... Read More →
avatar for Sai Jasti

Sai Jasti

Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D
Sai Jasti is Head of Data Science and AI for Bayer Pharma R&D. In this capacity, Sai is responsible for driving Digital, Data and Analytics for Pharma R&D. He is passionate about helping scientists discover transformative medicines faster and driving innovation using Machine learning... Read More →
avatar for Najat Khan, PhD

Najat Khan, PhD

Chief R&D Officer and Chief Commercial Officer, Recursion
Dr. Najat Khan is Recursion’s Chief R&D and Chief Commercial Officer, adding deep expertise in pharmaceutical innovation and data science to its leadership team.  Before joining Recursion, she served as the Chief Data Science Officer and Global Head of Strategy and Portfolio Organization... Read More →
avatar for Dr. Maria Luisa Pineda

Dr. Maria Luisa Pineda

CEO and Co-Founder, Envisagenics
Dr. Maria Luisa Pineda is the CEO and co-founder of Envisagenics. Dr. Pineda embarked on her career in STEM as a high school Intel International Science Fair winner in Miami after immigrating from Colombia in 2001. She received her doctorate from Cold Spring Harbor Laboratory School... Read More →
Tuesday January 14, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

2:00pm PST

Fireside Chat with Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA
Tuesday January 14, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
Moderators
avatar for Rebecca Willumson

Rebecca Willumson

SVP & Publisher, Fierce Life Sciences and Healthcare
Rebecca Willumson is the Senior Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of FierceBiotech, FiercePharma and FierceHealthcare.  She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital... Read More →
Speakers
avatar for Robert Zirkelbach

Robert Zirkelbach

Chief Public Affairs Officer & Head of Strategic Initiatives, Pharmaceutical Research and Manufacturers of America (PhRMA)
Robert Zirkelbach is Chief Public Affairs Officer & Head of Strategic Initiatives at the Pharmaceutical Research and Manufacturers of America (PhRMA). In this role, Mr. Zirkelbach oversees the organization’s media, advertising and executive communications efforts, along with message... Read More →
Tuesday January 14, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
  Presentation

2:20pm PST

Executive Interview: Victor Bulto, President, Novartis US
Tuesday January 14, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Victor Bulto

Victor Bulto

President, US, Novartis
As President of the US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.Victor is driven by the pressing need to translate... Read More →
Tuesday January 14, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
  Executive Interview

2:40pm PST

Championing Change: First Lady Jill Biden on Advancing Women’s Health Research and Innovation
Tuesday January 14, 2025 2:40pm - 3:00pm PST
Hyatt Regency San Francisco
This session will feature Dr. Jill Biden sharing her work and insights on the White House Initiative on Women's Health Research. The discussion will focus on the initiative's goal of transforming how we approach and fund women's health research, and how to continue building momentum to advance women’s health.
Moderators
avatar for Heather Landi

Heather Landi

Executive Editor, Fierce Healthcare
Heather Landi is an executive editor at Fierce Healthcare, responsible for the entire daily Fierce Healthcare brand and related team of editors. She previously served as senior editor, overseeing the team’s coverage of health IT and digital health news. With more than nine years... Read More →
Speakers
avatar for Dr. Jill Biden

Dr. Jill Biden

First Lady of the United States
Jill Biden, Ed.D., is the First Lady of the United States, a community college educator, a military mother, a grandmother, and bestselling author. Dr. Biden also served as Second Lady of the United States from 2009–2017. As First Lady, Dr. Biden has focused on reaching out to all... Read More →
Tuesday January 14, 2025 2:40pm - 3:00pm PST
Hyatt Regency San Francisco
  Keynote

3:00pm PST

Networking Break
Tuesday January 14, 2025 3:00pm - 3:10pm PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 3:00pm - 3:10pm PST
Hyatt Regency San Francisco
  Networking

3:10pm PST

Executive Interview: Sean Salmon, EVP & President, Cardiovascular, Medtronic
Tuesday January 14, 2025 3:10pm - 3:30pm PST
Hyatt Regency San Francisco
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Sean Salmon

Sean Salmon

Executive Vice President and President for the Cardiovascular Portfolio, Medtronic
Sean Salmon serves as Executive Vice President and President for the Cardiovascular Portfolio.Sean is responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all Operating... Read More →
Tuesday January 14, 2025 3:10pm - 3:30pm PST
Hyatt Regency San Francisco
  Executive Interview

3:30pm PST

Fireside Chat with Ramita Tandon, Chief BioPharma Services Officer, Walgreens
Tuesday January 14, 2025 3:30pm - 3:50pm PST
Hyatt Regency San Francisco
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Ramita Tandon

Ramita Tandon

Chief BioPharma Services Officer, Walgreens
As the Chief BioPharma Services Officer/Chief Clinical Trials Officer at Walgreens, Ramita Tandon is responsible for leading and driving growth for the Company’s new clinical research enterprise. In her role, Ramita works across the healthcare and life sciences industries to enable... Read More →
Tuesday January 14, 2025 3:30pm - 3:50pm PST
Hyatt Regency San Francisco
  Presentation

3:50pm PST

The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies
Tuesday January 14, 2025 3:50pm - 4:30pm PST
Hyatt Regency San Francisco
ADCs, bispecifics and radiopharmaceuticals are making waves in oncology treatment. Practice-changing clinical data have spurred major investments and deals. At the same time, much-touted cell therapies have run into real-world issues such as capacity and infrastructure limitations. During this panel, we will explore what’s next for these trends as the industry continues its efforts to advance patient care.
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Hesham Abdullah

Hesham Abdullah

Senior Vice President, Global Head Oncology, Research & Development, GSK
Hesham Abdullah is a seasoned physician-scientist who uniquely combines a clinician’s understanding of the impact cancer has on patients with deep expertise in identifying transformational opportunities to improve cancer treatment and care.As the head of GSK’s global oncology... Read More →
avatar for Teresa Bitetti

Teresa Bitetti

President of the Global Oncology Business Unit and a member of the Executive Team, Takeda
Teresa Bitetti is President of the Global Oncology Business Unit and a member of the Executive Team at Takeda, where she oversees a global portfolio of therapies targeting gastrointestinal, thoracic, and hematological cancers. In this role, Teresa leads all aspects of Takeda’s multi-billion-dollar... Read More →
avatar for Bassil I. Dahiyat, Ph.D.

Bassil I. Dahiyat, Ph.D.

President & Chief Executive Officer, Xencor
Bassil Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997. He is the co-founder of Xencor and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in creating a diverse clinical-stage portfolio... Read More →
avatar for Puja Sapra

Puja Sapra

Senior Vice President, Biologics Engineering and Oncology Targeted Discovery, AstraZeneca
I serve as Vice President, Tumour Targeted Delivery, Early Oncology. In my current role, I lead the research group dedicated to the discovery and preclinical development of targeted cancer therapeutics and novel delivery mechanisms that selectively attack cancer cells while sparing... Read More →
avatar for Mai-Britt Zocca, Ph.D.

Mai-Britt Zocca, Ph.D.

Founder and Chief Executive Officer, IO Biotech
Dr. Zocca brings more than 20 years of experience in the biotechnology field and has founded and co-founded several biotech spinouts. Her focus on translational and clinical immune oncology has led to the development of important investigational immunotherapies for a variety of cancer... Read More →
Tuesday January 14, 2025 3:50pm - 4:30pm PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

4:30pm PST

Reimagining Cancer Care with AI-Driven Spatial Biomarkers
Tuesday January 14, 2025 4:30pm - 4:50pm PST
Hyatt Regency San Francisco
Highlighting how AI-driven spatial biomarkers can transform drug development across the entire clinical lifecycle, from discovery to patient stratification and therapy optimization.
Speakers
avatar for B. Dusty Majumdar, PhD

B. Dusty Majumdar, PhD

CEO, PredxBio
Dusty Majumdar assumed the role of CEO at PredxBio in 2022, spearheading the company’s mission to lead the field of Spatial Biology through delving into the mechanism of action of cancer drugs and predicting patient outcomes with over 90% accuracy harnessing the power of AI-driven... Read More →
Tuesday January 14, 2025 4:30pm - 4:50pm PST
Hyatt Regency San Francisco
  Presentation

4:50pm PST

Executive Interview: Bahija Jallal, PhD, CEO, Immunocore
Tuesday January 14, 2025 4:50pm - 5:10pm PST
Hyatt Regency San Francisco
Moderators
avatar for Darren Incorvaia

Darren Incorvaia

Staff Writer, Fierce Biotech
Darren Incorvaia is a staff writer for Fierce Biotech. He joined Fierce in 2024 and has also written for The New York Times, Science, and Science News, among others. He was an early-career fellow at The Open Notebook in 2023 and has a Ph.D. in Ecology, Evolution and Behavior from... Read More →
Speakers
avatar for Bahija Jallal, PhD

Bahija Jallal, PhD

CEO, Immunocore
Dr Bahija Jallal is Chief Executive Officer and Director of the Board of Immunocore. Before joining Immunocore in January 2019, she served as President of MedImmune, AstraZeneca’s global biologics research and development unit. She was also Executive Vice President of AstraZeneca... Read More →
Tuesday January 14, 2025 4:50pm - 5:10pm PST
Hyatt Regency San Francisco
  Executive Interview

5:10pm PST

Closing Remarks
Tuesday January 14, 2025 5:10pm - 5:15pm PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Tuesday January 14, 2025 5:10pm - 5:15pm PST
Hyatt Regency San Francisco

5:15pm PST

Cocktail Networking Reception
Tuesday January 14, 2025 5:15pm - 6:15pm PST
Hyatt Regency San Francisco
Tuesday January 14, 2025 5:15pm - 6:15pm PST
Hyatt Regency San Francisco
  Networking
 
Wednesday, January 15
 

8:00am PST

Networking Breakfast
Wednesday January 15, 2025 8:00am - 8:50am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 8:00am - 8:50am PST
Hyatt Regency San Francisco
  Networking

8:00am PST

Registration
Wednesday January 15, 2025 8:00am - 3:00pm PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 8:00am - 3:00pm PST
Hyatt Regency San Francisco

8:50am PST

Opening Remarks
Wednesday January 15, 2025 8:50am - 9:00am PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Wednesday January 15, 2025 8:50am - 9:00am PST
Hyatt Regency San Francisco

9:00am PST

Fireside Chat: Tolga Tanguler, EVP and Chief Commercial Officer, Alnylam
Wednesday January 15, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Tolga Tanguler

Tolga Tanguler

Executive Vice President and Chief Commercial Officer, Alnylam
Tolga Tanguler joined Alnylam in January 2021 as Executive Vice President and Chief Commercial Officer with more than 20 years of experience in the global biopharmaceutical industry. At Alnylam, Tolga plays a pivotal role in scaling the company on a global stage, having expanded its... Read More →
Wednesday January 15, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco
  Keynote

9:20am PST

How can the Combination of Agentic and Human Intelligence Transform Drug Discovery, Development, and Diagnostics?
Wednesday January 15, 2025 9:20am - 9:50am PST
Hyatt Regency San Francisco
This panel will explore how agentic AI and human intelligence will transform drug development, from early-stage discovery and target identification to optimizing clinical trials and advancing personalized treatments. Key topics include AI’s role in accelerating research, improving trial design, and enhancing patient recruitment. The discussion will also address the challenges of understanding complex biology, ensuring data quality, and fostering cross-industry collaboration. By harnessing collective intelligence, the panel will highlight how these technologies can drive innovation, efficiency, and personalization across the drug development pipeline by harnessing collective intelligence.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Thomas Clozel, MD

Thomas Clozel, MD

Co-Founder & CEO, Owkin
Thomas is the CEO and Co-Founder of Owkin, leading medical research and business intelligence. He is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and a former member of Ari Melnick’s lab at Weill Cornell Medical College, where he co-led... Read More →
avatar for Emmanuel Frenehard

Emmanuel Frenehard

Executive Vice President, Chief Digital Officer, Sanofi
Emmanuel Frenehard oversees Sanofi’s digital, data and technology strategy to help transform the practice of medicine, empower healthcare professionals, and better serve patients.Emmanuel joined Sanofi four years ago. Prior to being appointed Chief Digital Officer, he held the positions... Read More →
avatar for Greg Meyers

Greg Meyers

Executive Vice President, Chief Digital & Technology Officer, BMS
Greg Meyers, executive vice president and chief digital and technology officer, leads the company’s efforts to coalesce digital technology alongside the company's transformational science to get more medicines, to more patients, faster and more impactfully.In his role, Greg leads... Read More →
avatar for Jorge S. Reis-Filho, MD PhD FRCPath

Jorge S. Reis-Filho, MD PhD FRCPath

VP Cancer Biomarker Development, Early Oncology,, AstraZeneca
Jorge S. Reis-Filho is the VP, Cancer Biomarker Development at AstraZeneca, whose mission is to develop mechanistically-informed but clinically-deployable biomarkers to deliver the right therapeutic agents to cancer patients at the right time during their therapeutic journey. Dr... Read More →
Wednesday January 15, 2025 9:20am - 9:50am PST
Hyatt Regency San Francisco
  Keynote

9:50am PST

Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
The biotech market made a comeback in 2024, recovering from a slump a year earlier. What will the IPO window look like in 2025? During this panel discussion, we will examine the performance of companies that went public in the second half of 2024 and how their success or challenges are impacting other startups’ decisions on whether to go public themselves
Moderators
avatar for Gabrielle Masson

Gabrielle Masson

Senior Editor, Fierce Biotech
Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →
Speakers
avatar for Jeffrey Finer, MD, PhD

Jeffrey Finer, MD, PhD

Chief Executive Officer and Co-Founder, Septerna
Jeffrey Finer, MD, PhD, is the Chief Executive Officer and Co-Founder at Septerna. Dr. Finer has more than 35 years of research, clinical and business experience. He has focused his career on breakthrough innovations that have included moving several first-in-class drugs into clinical... Read More →
avatar for Troy Ignelzi

Troy Ignelzi

CFO, Rapport Therapeutics
Troy has nearly two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised an impressive $4 billion-plus in capital for life science companies. Most recently, he was Chief Financial Officer at Karuna Therapeutics... Read More →
avatar for Maha Katabi

Maha Katabi

General Partner, Sofinnova Investments
avatar for Chirag D. Surti

Chirag D. Surti

Executive Director, Morgan Stanley
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

10:30am PST

Networking Break
Wednesday January 15, 2025 10:30am - 11:00am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 10:30am - 11:00am PST
Hyatt Regency San Francisco
  Networking

11:00am PST

Executive Interview: Kevin Conroy, CEO, Exact Sciences
Wednesday January 15, 2025 11:00am - 11:20am PST
Hyatt Regency San Francisco
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Kevin Conroy

Kevin Conroy

Chairman and CEO, Exact Sciences, Exact Sciences
Kevin Conroy became CEO of Exact Sciences in 2009 and Chairman in 2014, transforming the organization into one of the world’s premier cancer diagnostics companies with more than 6,500 employees. Under his leadership, Exact Sciences is working to change the future of cancer care... Read More →
Wednesday January 15, 2025 11:00am - 11:20am PST
Hyatt Regency San Francisco
  Executive Interview

11:20am PST

Pioneering Innovation in Drug Safety Solutions
Wednesday January 15, 2025 11:20am - 11:40am PST
Hyatt Regency San Francisco
The global Pharmacovigilance (PV)/Drug Safety market, valued at $8.5 billion in 2024, is projected to grow to $19.1 billion by 2034, reflecting the increasing importance of safety monitoring in life sciences R&D.  To support this growing trend, recent years have seen the emergence of innovative disruptors, reshaping traditional industry practices with new approaches and technologies.  A major trend in the industry has been the integration of advanced, AI-driven solutions that streamline and enhance PV operations.

In this session, Raj More, Chief Architect & CEO of RxLogix Corporation will discuss how a fully integrated AI-drive digital platform has the potential to expand into Clinical and Regulatory Information Management systems, paving the way for a holistic end-to-end Life Sciences platform. Mr. More will also highlight specific examples of how the RxLogix Safety Platform (RSP) drives substantial positive impacts for both life sciences companies and regulatory Agencies by increasing efficiency and allowing for consolidation and cost savings.
Speakers
avatar for Raj More

Raj More

Chief Architect & CEO, RxLogix Corporation
Raj started his career in PV/Drug Safety about 26 years ago at Relsys Internation, in Southern California. This is the company that built Argus Safety suite, and Raj was one of the key persons in building Relsys. Following the acquisition of Relsys by Oracle, Raj started RxLogix Corporation.As... Read More →
Wednesday January 15, 2025 11:20am - 11:40am PST
Hyatt Regency San Francisco
  Presentation

11:40am PST

Panel: Unlocking the Power of Healthcare Data: Advancing Access and Connectivity to Drive Patient Outcomes
Wednesday January 15, 2025 11:40am - 12:20pm PST
Hyatt Regency San Francisco
As healthcare embraces a more connected future, the need for real-time, global data access has become vital to bridging gaps in patient care and streamlining drug development. This panel delves into the challenges and opportunities in democratizing healthcare data, with a focus on integrated solutions and strategies that address data fragmentation and enable swift access to diverse patient and provider demographics. Join us to discover how democratizing healthcare data will shape the future of global patient care and catalyze advancements in the biopharma industry.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Ebony Dashiell-Aje, PhD

Ebony Dashiell-Aje, PhD

Executive Director & Head of Patient Centered Outcomes Science in Clinical Development, BioMarin
Ebony Dashiell-Aje, PhD is the Executive Director & Head of Patient Centered Outcomes Science in Clinical Development, at BioMarin. Dr. Dashiell-Aje is a leading expert in clinical outcome assessment (COA) and digital health technology development and optimization, including related... Read More →
avatar for Phil Johnson

Phil Johnson

Chief Commercial Officer, Evidation Health
Phil Johnson is Chief Commercial Officer at Evidation, applying real-world data to advance patient-centric health research and accelerate drug development. Leveraging Evidation’s community of over 5 million individuals and its innovative capabilities in direct-to-patient, longitudinal... Read More →
avatar for Jeffrey Helterbrand, Ph.D.

Jeffrey Helterbrand, Ph.D.

SVP, Data Sciences, Roche
Jeff is a Senior Vice President in PD Data Sciences (formerly Biometrics) at Roche. Data Sciences at Roche includes statisticians, patient-centered outcomes researchers, statistical programmers, clinical data managers, and medical data and information solution teams. Jeff is a member... Read More →
avatar for Ariel Katz

Ariel Katz

CEO and Co-Founder, H1
Ariel Katz is the CEO and Co-founder of H1, the connecting force for global HCP, clinical, scientific and research information. H1 works with the top Pharma and BioTech companies to deliver AI-powered insights to Medical Affairs and Clinical Operations to accelerate the discovery... Read More →
Wednesday January 15, 2025 11:40am - 12:20pm PST
Hyatt Regency San Francisco
  Panel

12:20pm PST

Networking Lunch
Wednesday January 15, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
  Networking

1:20pm PST

Panel: End of the Conglomerate Era
Wednesday January 15, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
Across the medtech industry, some of the largest players have shed entire divisions as they seek to narrow their focus on their core businesses. These moves range from J&J spinning out its Kenvue consumer operations, to Baxter selling off its multibillion-dollar kidney care unit, to GE HealthCare keeping the name of its conglomerate parent as it became an independent company. During this panel, we’ll explore the forces driving these divestitures and their effects on competition, branding, M&A and the broader market landscape—as well as whether elder firms have found success with smaller portfolios, and if the newcomers have found their footing.
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Ginny Blocki

Ginny Blocki

SVP, Global Marketing & Product Management, embecta
Ginny Blocki serves as the SVP, Global Marketing & Product Management of embecta, where she helped lead the business through a spinoff into an independent, publicly traded company. Since the spinoff, Ginny has been an integral part of the leadership team, focusing on corporate priorities... Read More →
avatar for Rachel Ellingson

Rachel Ellingson

Senior Vice President, Chief Administrative Officer, Zimmer Biomet
Rachel Ellingson was appointed Senior Vice President, Chief Administrative Officer in June 2024. In her role, she is responsible for strategy, business development (M&A execution and integration, strategic partnerships, divestitures and minority investments), as well as marketing... Read More →
avatar for Brian Montgomery

Brian Montgomery

Chief Strategy Officer, GE HealthCare
Brian leads Strategy for GE HealthCare, responsible for accelerating GE HealthCare’s strategic goals and leading the business development function.Immediately prior to his appointment, Brian was the acting Chief Financial Officer of GE HealthCare from June 2020 after serving as... Read More →
avatar for Arda Ural, PhD

Arda Ural, PhD

Americas Life Sciences Leader, Ernst & Young LLP
Arda Ural, PhD is the EY Americas Life Sciences Sector Leader. In this role, he is in service to EY life sciences professionals in North and South America, helping them to solve our clients’ most pressing issues at the C-suite level, building a sector community and upholding the... Read More →
Wednesday January 15, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
  Executive Interview

2:00pm PST

Fireside Chat with Jon Congleton, CEO, Mineralys
Wednesday January 15, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Jon Congleton

Jon Congleton

CEO, Mineralys Therapeutics
Jon Congleton has served as our Chief Executive Officer and as a member of our Board since November 2020. Prior to joining us, Mr. Congleton was the Chief Executive Officer of Impel NeuroPharma, Inc. from September 2017 to May 2020. Prior to that, he served as the Chief Executive... Read More →
Wednesday January 15, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
  Presentation

2:20pm PST

Executive Interview: Quita Highsmith, Vice President and Chief Diversity Officer, Genentech
Wednesday January 15, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
Moderators
avatar for Darren Incorvaia

Darren Incorvaia

Staff Writer, Fierce Biotech
Darren Incorvaia is a staff writer for Fierce Biotech. He joined Fierce in 2024 and has also written for The New York Times, Science, and Science News, among others. He was an early-career fellow at The Open Notebook in 2023 and has a Ph.D. in Ecology, Evolution and Behavior from... Read More →
Speakers
avatar for Quita Highsmith

Quita Highsmith

Vice President and Chief Diversity Officer, Genentech
Quita Highsmith is Vice President and Chief Diversity Officer at Genentech, a member of the Roche Group. At Genentech Quita was selected as the first Chief Diversity Officer in the 46-year history of the company and reports to the CEO. She is responsible for enterprise-wide strategic... Read More →
Wednesday January 15, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
  Executive Interview

2:40pm PST

Panel: Cell & Gene Therapy: Challenges, Trends and Technologies
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
With advancements in platform technologies and automation, the cell and gene therapy space is poised for changes. During this panel discussion, industry leaders will explore challenges and share insights on navigating regulatory hurdles, optimizing manufacturing and leveraging emerging technologies to address broader disease states.
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Christopher Arendt, Ph.D.

Christopher Arendt, Ph.D.

Chief Scientific Officer, Head of Research, Takeda
Based at Takeda’s Cambridge, Massachusetts, R&D campus, Christopher Arendt is responsible for oversight of Takeda’s Research and Early Development portfolio across Takeda’s core therapeutic areas of Gastroenterology andInflammation, Oncology, and Neuroscience.  Prior to his... Read More →
avatar for Kevin Forrest, Ph.D.

Kevin Forrest, Ph.D.

Co-Founder and former CEO, Kate Therapeutics
Kevin Forrest, Ph.D., was most recently co-founder, President, and CEO of Kate Therapeutics, a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.  Dr. Forrest led KateTx from inception through its acquisition... Read More →
avatar for Dr. Nadir Mahmood

Dr. Nadir Mahmood

President, Nkarta
Dr. Nadir Mahmood serves as President of Nkarta, where he is responsible for driving the company’s strategic focus, business excellence, and technical success. He previously served as the Chief Executive Officer of Rezo Therapeutics, a private-stage drug discovery company. Prior... Read More →
avatar for Cindy Perettie

Cindy Perettie

Executive Vice President, Kite, a Gilead Company
Cindy Perettie serves as Executive Vice President of Kite, a Gilead Company, and is responsible for overseeing the cell therapy business. Cindy joined Kite in 2023 with more than 20 years of scientific and commercial leadership experience in global biopharmaceutical organizations... Read More →
avatar for Shehnaaz Suliman, M.D., MBA, M.Phil.

Shehnaaz Suliman, M.D., MBA, M.Phil.

Chief Executive Officer, ReCode Therapeutics
Shehnaaz Suliman, M.D., MBA, M.Phil., serves as Chief Executive Officer of ReCode Therapeutics, a leading privately held biotechnology company powering the future of genetic medicines with a next-generation lipid nanoparticle platform. Lead programs are in primary ciliary dyskinesia... Read More →
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

3:20pm PST

Scaling Smarter: Ginkgo's Path to Sustained Growth and Operational Efficiency
Wednesday January 15, 2025 3:20pm - 3:40pm PST
Hyatt Regency San Francisco
Ginkgo Bioworks optimized its lab footprint through strategic decisions on equipment utilization and space allocation, driving significant operational efficiency. Using a data-driven approach, we achieved measurable reductions in lab space within just six months, aligning with 2024 targets for a leaner, more efficient operation. This case study also highlights broader lessons from Ginkgo’s journey toward operational excellence, showcasing how we adapted to an evolving market landscape, where some companies have faced challenging years. We’ll share insights into how restructuring and scalability efforts have positioned Ginkgo for sustainable growth.
Speakers
avatar for Priya Vijayakumar

Priya Vijayakumar

CEO, WattIQ
Priya Vijayakumar is the CEO and CO-Founder of WattIQ and has over 10+ years of experience creating and implementing global product strategy in the Industrial IoT markets across multiple startups.Priya holds a BSc in Chemical Engineering from the University of Toronto.
avatar for Doug Martinez

Doug Martinez

Senior Manager Lab & Infrastructure Operations, Ginkgo Bioworks
Doug Martinez is the Head of Lab Operations at Ginkgo Bioworks, a synthetic biology company offering tools and R&D solutions to accelerate projects across industries such as pharmaceuticals and agriculture. Over his five years at Ginkgo, he has been instrumental in supporting the... Read More →
Wednesday January 15, 2025 3:20pm - 3:40pm PST
Hyatt Regency San Francisco
  Presentation

3:40pm PST

Closing Remarks
Wednesday January 15, 2025 3:40pm - 3:45pm PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Wednesday January 15, 2025 3:40pm - 3:45pm PST
Hyatt Regency San Francisco
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Tuesday, January 14
Wednesday, January 15
Hyatt Regency San Francisco
  • Executive Interview
  • Keynote
  • Networking
  • Panel
  • Presentation